Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence
https://pubmed.ncbi.nlm.nih.gov/29732005/
Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting β-catenin signaling
https://pubmed.ncbi.nlm.nih.gov/29039569/
Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo
https://pubmed.ncbi.nlm.nih.gov/32625089/
Baicalin Inhibits Human Cervical Cancer Cells by Suppressing Protein Kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) Signaling Pathway
https://pubmed.ncbi.nlm.nih.gov/29610452/
Baicalin inhibits breast cancer development via inhibiting IĸB kinase activation in vitro and in vivo
https://pubmed.ncbi.nlm.nih.gov/30320365/
Baicalin triggers apoptosis, inhibits migration, and enhances anti-tumor immunity in colorectal cancer via TLR4/NF-κB signaling pathway
https://pubmed.ncbi.nlm.nih.gov/33742464/
Effect of baicalin on proliferation and apoptosis in pancreatic cancer cells
https://pubmed.ncbi.nlm.nih.gov/31632536/
Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway
https://pubmed.ncbi.nlm.nih.gov/23387975/